BPC-157 dosage chart for the 10 mg Vial: typical dose 200 mcg–600 mcg daily, reconstitution to 3.33 mg/mL, and protocol. For research use only.
BPC-157 Dosage Chart
BPC-157 is dosed at 200 mcg–600 mcg daily via subcutaneous injection in educational protocols. A 10 mg vial reconstituted with bacteriostatic water yields about 3.33 mg/mL. This information is for research and educational use only.
Reconstitute: Add 3.0 mL bacteriostatic water → 3.33 mg/mL concentration.
Typical daily range: 200–600 mcg once daily (gradual titration).
Easy measuring: At 3.33 mg/mL, 1 unit = 0.01 mL ≈ 33.3 mcg on a U-100 insulin syringe.
Storage: Lyophilized: freeze at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F); avoid freeze–thaw cycles.
BPC-157 (Body Protection Compound-157) is a synthetic 15-amino-acid peptide derived from a gastric protein sequence studied for tissue-healing and cytoprotective properties[1][2]. Preclinical models demonstrate accelerated wound repair and anti-inflammatory activity[3], though human clinical data remain limited to early-phase safety trials and small case reports[4][5]. This educational protocol presents a once-daily subcutaneous approach using a practical dilution for clear insulin-syringe measurements.
Research context: For evidence on mechanisms, human and preclinical research, limitations, and safety, read BPC-157 Peptide: Benefits, Uses, Side Effects, Dosage, and Research.
Dosing & Reconstitution Guide
Educational guide for reconstitution and daily dosing
Standard / Gradual Approach (3 mL = ~3.33 mg/mL)
{"order":20,"rows":[["Week","Daily Dose (mcg)","Units (per injection) (mL)"],["Weeks 1–2","200 mcg (0.2 mg)","6 units (0.06 mL)"],["Weeks 3–4","400 mcg (0.4 mg)","12 units (0.12 mL)"],["Weeks 5–8+","600 mcg (0.6 mg)","18 units (0.18 mL)"]],"skip_markdown":false,"type":"table"}
Frequency: Inject once daily subcutaneously. This schedule uses the largest practical dilution (3.0 mL) to keep per-injection units well above 5 for better accuracy. Dosing is extrapolated from preclinical models[1][6]; human clinical validation remains limited.
Reconstitution Steps
Draw 3.0 mL bacteriostatic water with a sterile syringe.
Inject slowly down the vial wall; avoid foaming.
Gently swirl/roll until dissolved (do not shake).
Label and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.
Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.
Supplies Needed
Plan based on an 8–16 week daily protocol with gradual titration.
Peptide Vials (BPC-157, 10 mg each): 8 weeks ≈ 3 vials (25.2 mg used) 12 weeks ≈ 5 vials (42 mg used) 16 weeks ≈ 6 vials (58.8 mg used)
8 weeks ≈ 3 vials (25.2 mg used)
12 weeks ≈ 5 vials (42 mg used)
16 weeks ≈ 6 vials (58.8 mg used)
Insulin Syringes (U-100): Per week: 7 syringes (1/day) 8 weeks: 56 syringes 12 weeks: 84 syringes 16 weeks: 112 syringes
Per week: 7 syringes (1/day)
8 weeks: 56 syringes
12 weeks: 84 syringes
16 weeks: 112 syringes
Bacteriostatic Water (10 mL bottles): Use ~3.0 mL per vial for reconstitution. 8 weeks (3 vials): 9 mL → 1 × 10 mL bottle 12 weeks (5 vials): 15 mL → 2 × 10 mL bottles 16 weeks (6 vials): 18 mL → 2 × 10 mL bottles
8 weeks (3 vials): 9 mL → 1 × 10 mL bottle
12 weeks (5 vials): 15 mL → 2 × 10 mL bottles
16 weeks (6 vials): 18 mL → 2 × 10 mL bottles
Alcohol Swabs: One for the vial stopper + one for the injection site each day. Per week: 14 swabs (2/day) 8 weeks: 112 swabs → recommend 2 × 100-count boxes 12 weeks: 168 swabs → recommend 2 × 100-count boxes 16 weeks: 224 swabs → recommend 3 × 100-count boxes
Per week: 14 swabs (2/day)
8 weeks: 112 swabs → recommend 2 × 100-count boxes
12 weeks: 168 swabs → recommend 2 × 100-count boxes
16 weeks: 224 swabs → recommend 3 × 100-count boxes
Protocol Overview
Concise summary of the once-daily regimen.
Goal: Support tissue-healing and recovery processes based on preclinical evidence[1][3].
Schedule: Daily subcutaneous injections for 8–12 weeks (extend to 16 weeks if desired).
Dose Range: 200–600 mcg daily with gradual titration.
Reconstitution: 3.0 mL per 10 mg vial (~3.33 mg/mL) for accurate unit measurements.
Storage: Lyophilized frozen; reconstituted refrigerated; avoid repeated freeze–thaw.
Dosing Protocol
Suggested daily titration approach.
Start: 200 mcg daily; increase by ~200 mcg every 2 weeks as tolerated.
Target: 400–600 mcg daily by Weeks 5–8+.
Frequency: Once per day (subcutaneous).
Cycle Length: 8–12 weeks; optional extension to 16 weeks.
Timing: Any consistent time; rotate injection sites.
Storage Instructions
Proper storage preserves peptide quality.
Lyophilized: Store at −20 °C (−4 °F) in dry, dark conditions; minimize moisture exposure.
Reconstituted: Refrigerate at 2–8 °C (35.6–46.4 °F); prepare aliquots if needed and avoid freeze–thaw.
Allow vials to reach room temperature before opening to reduce condensation uptake.
Important Notes
Practical considerations for consistency and safety.
Use new sterile insulin syringes for each injection; dispose in a sharps container[7].
Rotate injection sites (abdomen, thighs, upper arms) to reduce local irritation[8].
Inject slowly; wait a few seconds before withdrawing the needle.
Document daily dose and site rotation to maintain consistency.
BPC-157 human data are preliminary; clinical decisions should involve qualified healthcare providers.
How This Works
BPC-157 is a synthetic peptide corresponding to a partial sequence of human gastric juice protein[2]. Preclinical studies suggest it modulates nitric oxide pathways and growth-factor expression to promote angiogenesis and collagen deposition in damaged tissues[1][3]. Animal models report accelerated healing of gut, tendon, ligament, and muscle injuries[6]. A Phase I oral safety trial has been completed[9], and a small human case series reported improvements following intra-articular administration[5]; however, large-scale controlled human efficacy data are not yet available.
Potential Benefits & Side Effects
Observations from preclinical and early clinical literature.
Supports tissue repair in gut, tendon, muscle, and skin injury models (animal data)[1][3].
Demonstrates anti-inflammatory and cytoprotective properties in preclinical settings[6].
Phase I safety studies report good tolerability with no serious adverse events at tested doses[9].
Occasional mild injection-site reactions (redness, itch) may occur with subcutaneous administration.
Long-term human safety and efficacy remain under investigation[4].
Lifestyle Factors
Complementary strategies for best outcomes.
Support recovery with adequate protein intake and micronutrient-rich foods.
Balance activity and rest to allow tissue adaptation without overuse.
Prioritize sleep and stress management to enhance natural healing processes.
Consult qualified healthcare providers for injury-specific rehabilitation guidance.
Injection Technique
General subcutaneous guidance from clinical best-practice resources[10][11].
Clean the vial stopper and skin with alcohol; allow to dry.
Pinch a skinfold; insert the needle at 45–90° into subcutaneous tissue[10].
Do not aspirate for subcutaneous injections; inject slowly and steadily[10].
Rotate sites systematically (abdomen, thighs, upper arms) to avoid lipohypertrophy[8].
Discard used syringes immediately in a sharps container per WHO guidelines[7].
Important Note
This content is for educational purposes only and is not medical advice, diagnosis, or treatment. BPC-157 remains investigational with limited human clinical data. For research use only. Not for human consumption.
References
Journal of Pharmacological Sciences — Klicek R et al. BPC-157 promotes colocutaneous fistula healing via NO-system modulation (rat model) View Source
Pharmaceuticals (MDPI) — Józwiak M et al. Multifunctionality and possible medical application of BPC-157: literature and patent review (2025) View Source
Current Pharmaceutical Design (PMC) — Sikiric P et al. BPC-157 stable gastric pentadecapeptide: novel therapy for wound healing and tissue repair View Source
Life Sciences — Seiwerth S et al. BPC-157 and standard angiogenic growth factors: gastrointestinal tract healing and beyond View Source
HSS Journal (PubMed) — Vasireddi N et al. Emerging use of BPC-157 in orthopaedic sports medicine: systematic review (2025) View Source
Journal of Orthopaedic Research — Chang CH et al. BPC-157 promotes tendon-to-bone healing in a rat rotator cuff model View Source
WHO (NCBI Bookshelf) — Guideline on safety-engineered syringes for IM, ID, and SC injections in health care settings (2016) View Source
Johns Hopkins Arthritis Center — How to give a subcutaneous injection (patient education resource) View Source
ClinicalTrials.gov — NCT02637284: PCO-02 Phase I safety and pharmacokinetics trial of oral BPC-157 View Source
CDC — Vaccine administration: subcutaneous route (angle/site; no aspiration) View Source
Subcutaneous Drug Injection Review (PMC) — Pharmacologic considerations of the subcutaneous route View Source
Additional Research and Background
These sources provide related context and are not presented as support for a specific statement above.
World Journal of Gastroenterology (PMC) — Sikiric P et al. Pentadecapeptide BPC-157: from GI tract to whole body healing View Source
Related research, protocols, and guides
Explore the available research context, protocol variants or comparisons, and practical guides. When vial-size variants exist, they remain separate because vial strength, concentration, and syringe-unit calculations can differ. Related compounds and blends are comparisons only, not interchangeable.
Research overview
BPC-157 Peptide: Benefits, Uses, Side Effects, Dosage, and Research
Glow Peptide: Benefits, Uses, Side Effects, Dosage, and Research
KLOW Peptide: Benefits, Uses, Side Effects, Dosage, and Research
Other vial-size protocols
BPC-157 (5 mg Vial) Dosage Protocol
Related protocols and comparisons
BPC-157 + TB-500 (10 mg Blend) Dosage Protocol
BPC-157 + TB-500 (20 mg Blend) Dosage Protocol
TB-500 (5 mg) + BPC-157 (5 mg) Stack Dosage Protocol
Tri-Heal (45 mg Blend) Dosage Protocol
GLOW (70 mg Blend) Dosage Protocol
KLOW (80 mg Blend) Dosage Protocol
GHK-Cu (50 mg Vial) Dosage Protocol
GHK-Cu (100 mg Vial) Dosage Protocol
Practical guides
Single Peptide Dosages
Peptide Dosage & Reconstitution Calculator
How to Reconstitute Peptides
Syringe & Measurement Guide
Peptide Storage Guide
Peptide Dosage Chart
